Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder

被引:85
|
作者
不详
机构
关键词
bipolar disorder; mood stabilizers; practice parameter; practice guideline; DEFICIT HYPERACTIVITY DISORDER; PROSPECTIVE FOLLOW-UP; MANIC-DEPRESSIVE ILLNESS; OPEN-LABEL TRIAL; DIVALPROEX SODIUM; EARLY-ONSET; LITHIUM TREATMENT; MAJOR DEPRESSION; DIAGNOSTIC CHARACTERISTICS; PHARMACOLOGICAL-TREATMENT;
D O I
10.1097/01.chi.0000242240.69678.c4
中图分类号
B844 [发展心理学(人类心理学)];
学科分类号
040202 ;
摘要
This practice parameter reviews the literature on the assessment and treatment of children and adolescents with bipolar disorder. The parameter focuses primarily on bipolar 1 disorder because that is the type most often studied in juveniles. The presentation of bipolar disorder in youth, especially children, is often considered atypical compared with that of the classic adult disorder, which is characterized by distinct phases of mania and depression. Children who receive a diagnosis of bipolar disorder in community settings, typically present with rapid fluctuations in mood and behavior, often associated with comorbid attention-deficit/hyperactivity disorder and disruptive behavior disorders. Thus, at this time it is not clear whether the atypical forms of juvenile mania and the classic adult form of the disorder represent the same illness. The question of diagnostic continuity has important treatment and prognostic implications. Although more controlled trials are needed, mood stabilizers and atypical antipsychotic agents are generally considered the first line of treatment. Although patients may respond to monotherapy, combination pharmacotherapy is necessary for some youth. Behavioral and psychosocial therapies are also generally indicated for juvenile mania to address disruptive behavior problems and the impact of the illness on family and community functioning.
引用
收藏
页码:107 / 125
页数:19
相关论文
共 50 条
  • [41] Summary of the practice parameters for the assessment and treatment of children and adolescents with conduct disorder
    Steiner, H
    Dunne, JE
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1997, 36 (10): : 1482 - 1485
  • [42] Practice parameters for the assessment and treatment of children and adolescents with posttraumatic stress disorder
    Cohen, JA
    Bernet, W
    Dunne, JE
    Adair, M
    Arnold, V
    Benson, RS
    Bukstein, O
    Kinlan, J
    McClellan, J
    Rue, D
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1998, 37 (10): : 4S - 26S
  • [43] Practitioner Review: The assessment of bipolar disorder in children and adolescents
    Baroni, Argelinda
    Lunsford, Jessica R.
    Luckenbaugh, David A.
    Towbin, Kenneth E.
    Leibenluft, Ellen
    JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY, 2009, 50 (03) : 203 - 215
  • [44] Bipolar disorder in children: assessment in general pediatric practice
    Papolos, Demitri F.
    Bronsteen, Alissa
    CURRENT OPINION IN PEDIATRICS, 2013, 25 (03) : 419 - 426
  • [45] Practitioner review: The treatment of bipolar disorder in children and adolescents
    James, ACD
    Javaloyes, AM
    JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY, 2001, 42 (04) : 439 - 449
  • [46] Treatment of psychotic symptoms in children and adolescents with bipolar disorder
    Mick, E
    Biederman, J
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S270 - S270
  • [47] Profile of aripiprazole in the treatment of bipolar disorder in children and adolescents
    Kirino, Eiji
    ADOLESCENT HEALTH MEDICINE AND THERAPEUTICS, 2014, 5 : 211 - 221
  • [48] Treatment of psychotic symptoms in children and adolescents with bipolar disorder
    Biederman, J
    Mick, E
    BIOLOGICAL PSYCHIATRY, 2005, 57 (08) : 47S - 47S
  • [49] Pharmacologic Treatment Options for Bipolar Disorder in Children and Adolescents
    Stepanova E.
    Findling R.L.
    Current Treatment Options in Psychiatry, 2017, 4 (4) : 303 - 318
  • [50] Bipolar disorder in children and adolescents - A guide to diagnosis and treatment
    Silva, RR
    Matzner, F
    Diaz, J
    Singh, S
    Dummit, ES
    CNS DRUGS, 1999, 12 (06) : 437 - 450